INterview with Jeffrey Marx, Cerapedics president and COO

INterview with Jeffrey Marx, Cerapedics president and COO

Jeffrey (Jeff) G. Marx , Ph.D. is a senior executive with over 20 years of experience in the medical device space. His experience includes successful leadership roles spanning RD, business... Read More

Monday November 6, 2017 0 comments Tags: Denver, Jeffrey Marx, Cerapedics

Cerapedics appoints Doug Kohrs to board and names Antony Koblish chair

Cerapedics appoints Doug Kohrs to board and names Antony Koblish chair

WESTMINSTER -- Cerapedics , a privately-held orthobiologics company, announced the appointment of Doug Kohrs to the company's board of directors and the appointment of Antony Koblish as board... Read More

Wednesday October 25, 2017 0 comments Tags: Westminster, Cerapedics, Doug Kohrs, Antony Koblish, Glen Kashuba

Cerapedics receives $20M loan from Oxford Finance

Cerapedics receives $20M loan from Oxford Finance

WESTMINSTER -- Virginia-based Oxford Finance LLC announced closing a$20 millionsenior secured term loan with Cerapedics Inc. , a privately-held orthobiologics company engaged in the development... Read More

Thursday April 20, 2017 0 comments Tags: Westminster, Cerapedics, Oxford Financing, i-FACTOR, Christopher A. Herr, Glen Kashuba

Cerapedics announces closing of $11M Series D round to expand products

Cerapedics announces closing of $11M Series D round to expand products

WESTMINSTER -- Cerapedics , a privately-held orthobiologics company, today announced the completion of an $11 million Series D financing. The company said the funds will be used to expand... Read More

Friday September 30, 2016 0 comments Tags: Westminster, Cerapedics, Glen Kashuba, i-FACTOR

CBSA: 2015 was groundbreaking year for life sciences industry

CBSA: 2015 was groundbreaking year for life sciences industry

DENVER -- Colorados life sciences sector had a robust and groundbreaking 2015, according to the Colorado BioScience Association (CBSA), the states advocate for the industry. CBSA reported... Read More

Wednesday December 16, 2015 0 comments Tags: Denver, CBSA, April Giles, Medtronic, Covidien, Nivalis Therapeutics, Precision Biopsy, miRagen Therapeutics, Spectranetics, Surefire Medical, Cerapedics, dbMEDx, Clovis Oncology

Cerapedics gets FDA approval for i-FACTOR bone graft to repair cervical disc degeneration

Cerapedics gets FDA approval for i-FACTOR bone graft to repair cervical disc degeneration

WESTMINSTER -- Cerapedics , a privately-held orthobiologics company, announced the FDA has approved the companys Premarket Approval application for i-FACTOR Peptide Enhanced Bone Graft for use in... Read More

Wednesday November 4, 2015 0 comments Tags: Westminster, Cerapedics, i-FACTOR, bone grafts, Jeffrey G. Marx, Glen Kashuba, FDA

Cerapedics closes on $4M loan from GE Capital

Cerapedics closes on $4M loan from GE Capital

WESTMINSTER Cerapedics , a privately-held orthobiologics company, today announced closing of a $4 million term loan from GE Capital Healthcare Financial Services, bringing the total facility to... Read More

By: InnovatioNews Tuesday April 7, 2015 0 comments Tags: Westminster, Cerapedics, Glen Kashuba, i-FACTOR, GE Capital

Cerapedics receives OK in Europe and Australia to use its i-FACTOR Flex FR biologic bone graft

Cerapedics receives OK in Europe and Australia to use its i-FACTOR Flex FR biologic bone graft

WESTMINSTER - Cerapedics , a privately held orthobiologics company, announced it has received the CE Mark in Europe and Therapeutic Goods Administration (TGA) listing in Australia for its new... Read More

By: InnovatioNews Thursday January 15, 2015 0 comments Tags: Cerapedics, Glen Kashuba, i-FACTOR Flex FR, Niall Craig, P-15 technology, Westminster